Reuters logo
BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​
November 9, 2017 / 1:21 PM / a month ago

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

Nov 9 (Reuters) - Sienna Biopharmaceuticals Inc

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

* Sienna Biopharmaceuticals Inc - Qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals Inc - ‍Sienna’s cash and cash equivalents as of Sept. 30, 2017, totaled approximately $88.6 million​

* Sienna Biopharmaceuticals - ‍ Expects non-cash component related to acquisition of creabilis to continue to impact G&A expenses in future quarters​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below